The Young Stroke Physicians and Researchers (YSPR) Committee, composed of young members of the European Stroke Organisation, is dedicated to promoting the involvement of young stroke physicians and researchers in the ESO and the broader field of stroke care. On behalf of the YSPR, Dr Sarah Gorey highlights some key challenges in stroke-related care, as well as recent innovations in treatment.
The impact abdominal fat has on brain health and cognition has also been found to be more pronounced in middle-aged men at high risk of Alzheimer's disease compared to women.
A £5 million project started in the UK last year aims to enable individuals to receive Alzheimer's diagnoses within seconds through the National Health Service (NHS) within the next five years.
Multiple sclerosis (MS) is a disease that impacts the central nervous system, affecting everything we do. For many patients, the main question is: how do I confront this life-changing condition?
The World Health Organization (WHO) has certified Cabo Verde as a malaria-free country, marking a significant achievement in the global fight against the disease.
Scientists from the University of Liverpool and Liverpool School of Tropical Medicine (LSTM) have taken a huge step forward in combating the global threat of malaria.
35.3% of British adults are likely to have prediabetes. Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, argues that increased diabetes testing is needed to ensure 18 million people don’t go on to develop ‘full-blown’ diabetes.
Psoriasis is a chronic immune-mediated inflammatory disease that can impact sufferers’ mental and physical health. We discuss the complexity of the condition as well as the emergence of effective treatments with the national UK charity The Psoriasis Association.
Biologic therapies can effectively control severe asthma without the need for regular high-dose inhaled steroids, a significant revelation that could transform the lives of millions grappling with the condition.
The need for public health officials to be able to model the spread of an infectious disease has never been more apparent than in the early days of the SARS-CoV-2 pandemic.
